Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study.
about
Case-based study: from prediabetes to complications--opportunities for preventionHMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysisMilk and dairy consumption, diabetes and the metabolic syndrome: the Caerphilly prospective studyLow-carbohydrate and high-fat intake among adult patients with poorly controlled type 2 diabetes mellitusNeurohumoral stimulation in type-2-diabetes as an emerging disease conceptMetabolic effect of telmisartan and losartan in hypertensive patients with metabolic syndromeImaging of coronary atherosclerosis in various susceptible groupsNeuroendorine and Epigentic Mechanisms Subserving Autonomic Imbalance and HPA Dysfunction in the Metabolic SyndromeInsulin-like growth factor-1 deficiency and metabolic syndromeTreatment of metabolic syndromeMetabolic syndrome, inflammation and atherosclerosisEffects of exercise and diet on chronic diseaseSerum hepatic enzyme activity and alcohol drinking status in relation to the prevalence of metabolic syndrome in the general Japanese populationHeterogeneity in sex differences in the metabolic syndrome in Dutch white, Surinamese African and South Asian populations.Bridging Type 2 Diabetes and Alzheimer's Disease: Assembling the Puzzle Pieces in the Quest for the Molecules With Therapeutic and Preventive PotentialComprehensive Cardiovascular Risk Reduction and Cardiac Rehabilitation in Diabetes and the Metabolic Syndrome.Effects of a community-based healthy heart program on increasing healthy women's physical activity: a randomized controlled trial guided by Community-based Participatory Research (CBPR).The obesity, metabolic syndrome, and type 2 diabetes mellitus pandemic: Part I. Increased cardiovascular disease risk and the importance of atherogenic dyslipidemia in persons with the metabolic syndrome and type 2 diabetes mellitusThe obesity, metabolic syndrome, and type 2 diabetes mellitus pandemic: II. Therapeutic management of atherogenic dyslipidemia.The metabolic syndrome and mind-body therapies: a systematic review.Risk factors for metabolic syndrome independently predict arterial stiffness and endothelial dysfunction in patients with chronic kidney disease and minimal comorbidity.Association of hormonal dysregulation with metabolic syndrome in older women: data from the InCHIANTI study.Adverse prognosis associated with the metabolic syndrome in established coronary artery disease: data from the EUROPA trialApplication of recent definitions of the metabolic syndrome to survey data from the National Cholesterol Education Program Evaluation Project Utilizing Novel E-Technology (NEPTUNE II).Change in metabolic syndrome parameters with antipsychotic treatment in the CATIE Schizophrenia Trial: prospective data from phase 1Metabolic syndrome as a cardiovascular disease risk factor: patients evaluated in primary care.Presence of the metabolic syndrome is not a better predictor of cardiovascular disease than the sum of its components in HIV-infected individuals: data collection on adverse events of anti-HIV drugs (D:A:D) study.Rosiglitazone decreases C-reactive protein to a greater extent relative to glyburide and metformin over 4 years despite greater weight gain: observations from a Diabetes Outcome Progression Trial (ADOPT)The metabolic syndromeHypertriglyceridemia influences the degree of postprandial lipemic response in patients with metabolic syndrome and coronary artery disease: from the CORDIOPREV study.Metabolic syndrome as a predictor of type 2 diabetes, and its clinical interpretations and usefulness.Epidemiological and economic burden of metabolic syndrome and its consequences in patients with hypertension in Germany, Spain and Italy; a prevalence-based model.Folic acid treatment normalizes NOS-dependence of vascular tone in the metabolic syndrome.Role of C-reactive protein in contributing to increased cardiovascular risk in metabolic syndrome.Fiber intake and inflammation in type 1 diabetes.Recurrence of Disease Following Liver Transplantation: Nonalcoholic Steatohepatitis vs Hepatitis C Virus InfectionComorbidity and metabolic syndrome in patients with multiple sclerosis from Asturias and Catalonia, SpainMolecular determinants of the cardiometabolic phenotype.Metabolic syndrome, independent of its components, is a risk factor for stroke and death but not for coronary heart disease among hypertensive patients in the ASCOT-BPLA.Heart disease risk among metabolically healthy obese men and metabolically unhealthy lean men
P2860
Q21144738-CE35467B-68C7-41A7-BE41-486EDA28FF30Q24194514-F5F32CD7-F0C9-4D5E-8C8A-33C26FC19684Q24643376-7FC84641-2C3E-4955-928C-FBAE82C51BFEQ24676853-3F1CA793-9F02-4DFA-9D85-3788C40DECBBQ24798310-FE9D6A91-0D7D-469A-8BF3-04016DF69A00Q24816197-E4EBB453-4BDC-4829-A141-422DC30A39FFQ26738569-16D8BAD6-6FCB-48EC-A6C6-41A46790D5E3Q26752744-1E884EAB-5743-451D-9ADE-9729CA73FC16Q28072410-BDE887AA-5A59-4115-9AF2-0B8031D273D3Q28168652-17886482-FAAD-4D50-B6B8-E6C144C1E7F9Q28219348-A96E1616-E36A-442C-9746-6D8C6131836CQ28297798-A8179E28-95F2-41F3-9499-4117F7369208Q28538138-3D03E057-243A-4CB7-BCC8-1916970EA2E8Q29353804-BB9571DC-8AD4-45E1-9F51-8320DD21A206Q29994589-01338696-0827-4743-9F7A-05EDF357EE55Q30244968-17C64708-F261-4F24-B10D-16907A158681Q30363587-AEAFEA4F-BD8A-40AC-A94C-989148744C23Q30379006-E4537421-0268-4537-8FC1-6484DF7FA1EDQ30380628-66A19CD5-49D2-4F31-BD55-36D089A0A23FQ30405042-B815BBE7-9C4D-4E10-84F7-CFACDFC3589EQ30521471-B96D2BFD-4662-4159-95C8-C6BFC8D8373FQ31060630-58DA1248-B418-4552-8982-A8DE41E6753CQ31114345-924A3295-9BBE-4F46-8DDB-6E36D35E964DQ31120863-41C95DE7-67EB-4C1D-AAA4-A2DEE4A7DCC6Q31145823-653E97BD-BB8E-469F-AD8A-0EC890AF7491Q33353821-08C3B5B8-9027-409D-ADBA-7D41F91908C7Q33389734-1DD4A8F0-5BA0-4504-91E7-B22917789A86Q33556796-08ABC333-0EF0-4EF8-A554-2621181C348BQ33569142-E3DB2E55-7B44-4F1C-93E4-55E444147AF0Q33572736-0FEA8D20-FB5B-4FB7-BBCD-C667C8B7822FQ33607601-A951BC2B-D250-49BE-A3B9-91DE10D31096Q33682776-A66F5675-A59B-46D9-B4BA-0B165A82F082Q33701506-CD34DBD3-AE86-48FF-817E-7227E22E7DA0Q33788524-1FA77E3F-535F-4058-8310-BEAC6B6BDC8BQ33851372-595CD0A5-9B30-4B7D-95FA-2D48E3A93416Q33871776-2EE34FA0-285D-4FCE-91F3-67B86F458166Q33908614-CC134F2E-24E1-4115-855A-58B4EE0E4F91Q33921392-2CC286F6-36E7-459F-9768-03B6E3CFF6A9Q33932865-BFDAF1AA-7224-48AF-8F99-1E652F9A3C66Q33938952-4DBA766B-7C59-4ACE-858C-BACB3923A53E
P2860
Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Metabolic syndrome with and wi ...... and Coronary Prevention Study.
@en
Metabolic syndrome with and wi ...... and Coronary Prevention Study.
@nl
type
label
Metabolic syndrome with and wi ...... and Coronary Prevention Study.
@en
Metabolic syndrome with and wi ...... and Coronary Prevention Study.
@nl
prefLabel
Metabolic syndrome with and wi ...... and Coronary Prevention Study.
@en
Metabolic syndrome with and wi ...... and Coronary Prevention Study.
@nl
P2093
P1433
P1476
Metabolic syndrome with and wi ...... and Coronary Prevention Study.
@en
P2093
Chris Isles
Chris J Packard
Denis St J O'Reilly
James Shepherd
Olga Scherbakova
Peter W Macfarlane
Steven M Haffner
Stuart M Cobbe
P304
P356
10.1161/01.CIR.0000080897.52664.94
P407
P577
2003-07-14T00:00:00Z